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Current Concepts of Metabolic Functional Imaging
with Positron Emitters
John W. Keyes, Jr, M D *
Positron emitting radionucUdes have unique properties that
make them nearly ideal as radioactive tracers for in vivo
metabolic studies. Using positron emission tomographic
(PET) scanning and positron-labeled
radiopharmaceuticals,
one can study local glucose metabolism in dssues, blood

flow, oxygen udlizadon, protein synthesis, and many ot/,e
functions noninvasively in normal subjects and patients who
have various diseases. A review of some of these techniques
and the relative advantages and problems associated with
the PET approach is presented.

Developments in radiopharmaceutical science, nuclear
medicine imaging technology, and computer modeling of
biological processes have led to techniques that now permit the noninvasive measurement of basic physiologic processes within the human body. Determination of blood flow
in tissues, local glucose metabolism in tissues, utilization of
oxygen, efficiency of oxygen extraction from blood, and measurements of local receptor density and binding activity are
all possible. The nuclear medicine techniques that make
possible these determinations are designated the collective
name of positron emission tomography (PET).

annihilation reaction. These gamma photons, which carry the
energy equivalent of the rest-mass of two electrons, are given
off in exactly 180° opposite directions from one another, pro.
viding an ideal format for external detection and localization. This pair of annihilation gamma rays are the means for
easy, quantitative, noninvasive localization within the body,

Requirements for Functional Imaging
To measure a physiologic process within the body (for example, local glucose metabolism in tissues), it is necessary
to have a tag or tracer for glucose that can be accurately
followed through the metabolic process. The ideal tracer
must not disturb the measured physiologic process, must be
safe, and should be measurable from outside the body for
in vivo studies.
Commonly used positron radionuclides include positron
emitting isotopes of carbon, oxygen, and nitrogen, which are
the basic building-block atoms of organic molecules, and
fluorine-18, which can be substituted for hydrogen in many
organic molecules without significantly changing their biophysical behavior. These four radioisotopes provide positron
emitting tags that can be synthesized into physiologically important substrates without altering the chemical or biophysical behavior of these substrates within the body. Thus, they
meet the first criterion for an ideal tracer, not altering normal body biochemistry.
The positron mode of radioactive decay is unique among
the radioactive tracers currently used for nuclear medicine
imaging. The positron emitted during such decay represents
an electron with a positive charge. Such a particle, unable
to exist in normal matter, promptly undergoes what is called
an annihilation reaction with a normal (negatively charged)
electron. To satisfy the requirement for conservation of
energy, two gamma rays are emitted as a result of this
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When considering the use of radioactive tracers, safety usual-,
ly refers to limiting patient radiation from the tracer. Positron-1
labeled tracers are usually safe for two reasons. First, because'
of the extremely short physical half-life of most positron emitters (Table) the radioactivity disappears from the body rapidly.
Thus, total time of exposure is short, and the total integrated
radiation dose is small. Second, because it is often possible
to synthesize labeled compounds with high specific activities, only small amounts of labeled material must be administered to be detected.
The 180° opposed pair of annihilation photons provides
ideal geometry for external localization and quantification
of radiotracers within the body. The key to accurate extemal
tracer imaging has been the development of positron emission tomographs, so-called PET scanners. The fact that a pair
of gamma rays traveling in exactly opposite directions is emit'
ted with each annihilation event is used to determine exactly the line along which the annihilation event occurred.
Detectors placed on opposite sides ofthe body are directed
toward each other and operated in what is known as the coincidence mode, wherein a radioactive decay event is no*!
counted unless both detectors simultaneously detect a gamma ray. A ring of such detectors surrounding the body si'
multaneously measure the multiple lines of localization for
many individual radioactive decay events. With this information and computer technology, a computed tomograp''
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Table

tracer can be synthesized in a short enough period of time.
Methods for studying a large number of physiologic processes
have already been developed and applied to many normal
and pathologic conditions. A large percentage of PET research has focused on normal and abnormal central nervous
system (CNS) function. A few selected examples serve to introduce the beauty and depth of these techniques.

Position Emitting Radionuclides in Current Use
Radionuclide

Physical Half-Life (minutes)

Oxygen-15
Carbon-11
Nitrogen-13
Fluorine-18
Gallium-68
Rubidium-81
Rubidium-82

2.1
20.4
10.0
110.0
68.5
274.8
1.3

Imaging

ofthe distribution of radioactivity is calculated. The mathematics are exactly the same as those used in X-ray computed
tomography, but the resulting tomogram shows the distribution of radioactivity rather than X-ray density. Ifthe measurements are made properly and certain correction factors are
applied, the resulting computed tomogram is a quantitatively accurate map of the distribution of radioactive tracer within a volume section of the body.
Modern PET scanners simultaneously produce multiple, contiguous tomographic images. In effect, such multisection PET
scanners provide a three-dimensional image ofthe distribution of radioactive tracer within a given part of the body.
Thus, using an appropriately selected positron-labeled radiopharmaceutical and a modern, multisection PET scanner,
maps are constructed of the distribution and time-course of
the metabolism of physiologic substrates within the body.
Finally, the use of positron technology to study in vivo processes requires a computerized mathematical model ofthe
metabolism of a given physiologic substrate. For example,
the tracer i'*F-fluoro-2-deoxy-D-glucose (FDC) is a positronlabeled analog of glucose. After intravenous administration
ofthe tracer, its distribution within the body is related to the
local rate of glucose metabolism by specific tissues. The ratio
of the absolute tracer uptake of a specific tissue and the actual rate of glucose metabolism within that tissue is not one
to one, however. Detailed knowledge of how the tracer is
metabolized and localized within the tissue is necessary to
evaluate results of the study. Knowledge of the exact process permits construction of a mathematical model and a
computer program that will convert the initial PET scan of
FDC detected within the tissue into a map of local glucose
metabolism.

Cerebral glucose metabolism rate
When administered intravenously, the tracer FDC enters the
metabolized pool of glucose and is taken up by cells that
are actively metabolizing glucose. Once within the cell, FDC
is phosphorylated but cannot progress further in the metabolic pathway for glucose. In essence, the labeled compound
becomes trapped in the cell. By obtaining a PET scan after
the administration of FDC, the local rate of glucose metabolism can be calculated using an appropriate computer
model, and the result can be presented as a functional image, a quantitative map of the rate of glucose metabolism
in the tissue (1).
Figure 1 is an example of such a functional image of glucose metabolism in the normal human brain. Images are
shown at four levels. The darker the area, the greater the local
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Currently, models are available for accurately measuring
local tissue glucose metabolism rates (1,2), blood flow within specific tissues (3-5), oxygen utilization within specific
tissues (4,5), and the extraction fraction of oxygen from blood
circulation through a given organ or area of an organ (4).
^ great deal of work now underway is designed to measure
'ocal tissue receptors for a variety of biochemical messengers (6,7). Similarly, investigators are trying to develop accurate models for parameters such as blood-brain barrier per'Tieability and local rates of protein synthesis (8).

Applications of PET Scanning
Every physiologic/metabolic process is potentially amenable
"mvestigation using PET techniques, provided a suitable
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Fig 1
Computer processed functional images depicting glucose metabolic rate
in healthy 26-year-old male volunteer. Scale is in mg of glucose metabolized
per minute per 100 g of tissue. Sections are contiguous; A = lowest,
D = highest. (Courtesy of University of Michigan.)

Keyes

Cerebral blood flow
A number of methods have been developed to measure cere,
bral blood flow using PET methods (3-5). Figure 3 is a repre.
sentative example of a functional map of cerebral blood flow
in a normal individual. The tracer was oxygen-15 labeled
water. As expected in this normal subject, the local cerebral
blood flow rather closely paralleled the local cerebral metabolic rate for glucose (Fig 1). This parallelism does not exist
in many disease states; physiologic/metabolic imbalances
have been documented in such states as acute stroke, luxuryperfusion syndrome, misery-perfusion syndrome, and
neoplasm (3,4).

B

Other applications
Much excellent work relating PET methods to heart and myocardial metabolism has been accomplished. Because the
heart normally uses free fatty acids as a primary substrate
for energy metabolism, carbon-11 labeled palmitic acid is
an excellent tracer for determination of myocardial metabolism. Schon et al produced functional images of local myocardial fatty acid metabolic rate and have studied a wide
variety of cardiac conditions with this technique (17).

Problems and Predictions
The ability to make such elegant measurements of various

Fig 2
Images of glucose metabolism rate in four patients with left middle cerebral
artery infarct (A), Huntington's chorea (B), left temporoparietal glioma
(O, and left temporal lobe epilepsy (D). (Courtesy of University of Michigan.)

metabolic rate. Note the clear localization of glucose metabolism in the cerebral gray matter, the basal ganglia, and the
thalamus; much lower rates of glucose utilization are seen
within white matter.
Figure 2 shows representative sections of four patients who
have, respectively, a left hemispheric stroke, Huntington's
chorea, a large glioma, and left temporal lobe epilepsy. Note
the decreased glucose utilization within the area of infarct,
disclosing the tissue injury and loss of function within this
area. In the patient who has Huntington's chorea, the study
demonstrated a striking loss of glucose in the area of the caudate nuclei (compare with Fig 1), concordant with the anatomic abnormality found in such patients.
In addition to many studies of various CNS diseases (2-4,
9-14), PET scanning has been used extensively to study normal CNS function (2,5,15). Striking alterations in regional
glucose utilization in the brain occur with various normal
physiologic functions such as listening, memorizing, and seeing (15,16). For example, Mazziotta and coworkers (15)
demonstrated changes in lateralization of function related
to hearing that depended on whether the individual was listening to music or speech.
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Fig 3
Functional image of cerebral blood flow in normal subject. Calculated
"O-HjO method. (Courtesy of University of Michigan.)

Metabolic Imaging

hysiologic processes within the body is bought at a price,
however. The physical half-life ofthe various positron emitjipg radioisotopes is quite short (Table). Fluorine-18, for exampIS' has a physical half-life of less than two hours, and
oxygen-'iS, a half-life of only two minutes. Elaborate and
fechnologically complex solutions are required in order to
jse tracers that have such an evanescent existence. Typically a fully equipped radiosynthetic chemistry laboratory is
needed immediately adjacent to the scanning site. Most positron emitting radionuclides are produced using cyclotrons
thatare small enough to be installed and operated physically
close to a medical research facility. A large number of positron research sites developed around the world in recent
years have on-site cyclotrons for the local, immediate production ofthe tracer radioisotopes that they use. However,
in their present state of development, these machines are not
suitable for routine clinical production of radionuclides.

Metabolic research using positron-labeled radiotracers
requires a relatively elaborate and technically complex
underpinning. An on-site cyclotron, a specially tailored radiochemistry and radiopharmaceutical synthetic facility, a PET
scanner, and relatively sophisticated computing and image
processing facilities are all necessary to conduct such research successfully. Work is currently underway in many
centers to simplify, miniaturize, and automate many ofthese
procedures; it may be possible in the future to incorporate
positron technology into general patient care, at least at large
tertiary care centers. For the present, this approach to medical
imaging and physiologic research remains a highly specialized, albeit extremely elegant and productive, means of
examining the human body.
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